Eric d'Esparbes

2021 - BIORA THERAPEUTICS

In 2021, Eric d'Esparbes earned a total compensation of $1.6M as Executive Vice President, Chief Financial Officer and Principal Financial Officer at BIORA THERAPEUTICS, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$130,000
Option Awards$555,478
Salary$471,635
Stock Awards$420,733
Other$17,670
Total$1,595,516

d'Esparbes received $555.5K in option awards, accounting for 35% of the total pay in 2021.

d'Esparbes also received $130K in non-equity incentive plan, $471.6K in salary, $420.7K in stock awards and $17.7K in other compensation.

Rankings

In 2021, Eric d'Esparbes' compensation ranked 6,991st out of 12,415 executives tracked by ExecPay. In other words, d'Esparbes earned more than 43.7% of executives.

ClassificationRankingPercentile
All
6,991
out of 12,415
44th
Division
Manufacturing
3,062
out of 5,505
44th
Major group
Chemicals And Allied Products
1,356
out of 2,375
43rd
Industry group
Drugs
1,209
out of 2,096
42nd
Industry
Pharmaceutical Preparations
881
out of 1,546
43rd
Source: SEC filing on April 28, 2022.

d'Esparbes' colleagues

We found six more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2021.

2021

Adi Mohanty

BIORA THERAPEUTICS

Chief Executive Officer

2021

Harry Stylli

BIORA THERAPEUTICS

Chief Executive Officer

2021

Clarke Neumann

BIORA THERAPEUTICS

General Counsel

2021

Matthew Cooper

BIORA THERAPEUTICS

Chief Scientific Officer

2021

Sami Shihabi

BIORA THERAPEUTICS

Former Chief Commercial Officer

2021

Hutan Hashemi

BIORA THERAPEUTICS

Former Chief Compliance Officer

News

You may also like